Compare LZB & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LZB | PRCT |
|---|---|---|
| Founded | 1927 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 1994 | 2021 |
| Metric | LZB | PRCT |
|---|---|---|
| Price | $35.69 | $25.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $42.50 | $38.25 |
| AVG Volume (30 Days) | 380.0K | ★ 1.6M |
| Earning Date | 05-18-2026 | 05-27-2026 |
| Dividend Yield | ★ 2.71% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $2,349,433,000.00 | $308,054,000.00 |
| Revenue This Year | $2.36 | $39.90 |
| Revenue Next Year | $3.57 | $24.91 |
| P/E Ratio | $21.59 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $29.03 | $19.35 |
| 52 Week High | $44.49 | $65.69 |
| Indicator | LZB | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 42.27 |
| Support Level | $32.35 | N/A |
| Resistance Level | $39.84 | $36.93 |
| Average True Range (ATR) | 1.38 | 1.72 |
| MACD | -0.15 | -0.26 |
| Stochastic Oscillator | 47.60 | 60.59 |
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.